Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/26/2012 | EP2501229A1 Compounds and methods for altering lifespan of eukaryotic organisms |
09/26/2012 | EP2501228A1 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom |
09/26/2012 | EP2501227A1 Treatment of ophthalmic conditions with fluorenone derivatives |
09/26/2012 | EP2056829B9 Using pi3k and mek modulators in treatments of cancer |
09/26/2012 | EP1753852B1 Compositions with health and nutrition promoting characteristics, containing interestified lipids and phytosterol esters, and related methods |
09/26/2012 | CN202447061U Device for preparing functional nano particles through depressurization-induced microjet mixing method |
09/26/2012 | CN1950342B Novel compounds as opioid receptor modulators |
09/26/2012 | CN1947717B Method for treating neuronal and non-neuronal pain |
09/26/2012 | CN1938294B Novel pyrrolidine-3,4-dicarboxamide derivatives |
09/26/2012 | CN1914225B HCV NS-3 serine protease inhibitors |
09/26/2012 | CN1798576B Drug for preventing or treating angiogenic eye diseases |
09/26/2012 | CN1791395B 免疫抑制剂化合物及组合物 Immunosuppressive compounds and compositions |
09/26/2012 | CN1764462B T-type calcium channel blockers |
09/26/2012 | CN1738618B Pharmaceutical compositions and uses thereof |
09/26/2012 | CN1674866B New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
09/26/2012 | CN1662663B DNA enzyme to inhibit plasminogen activator inhibitor-1 |
09/26/2012 | CN1571765B Esters of aromatic alkoxylated alcohols and fatty carboxylic acids |
09/26/2012 | CN102695797A Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene |
09/26/2012 | CN102695796A Cells, nucleic acids, enzymes, and use thereof, and methods for the production of sophorolipids |
09/26/2012 | CN102695710A Tricyclic pyrazol amine derivatives |
09/26/2012 | CN102695709A Crystalline forms of substituted pyrazolopyrimidines |
09/26/2012 | CN102695708A N1-pyrazolospiroketone acetyl-coA carboxylase inhibitors |
09/26/2012 | CN102695706A Imidazopyridine derivatives as JAK inhibitors |
09/26/2012 | CN102695704A Indole derivatives and methods for antiviral treatment |
09/26/2012 | CN102695702A ABT-263 crystalline forms and solvates for use in treating BCL-2 protein related diseases |
09/26/2012 | CN102695701A MGLU2 agonists |
09/26/2012 | CN102695700A Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors |
09/26/2012 | CN102695697A Novel multifunctional peptidase inhibitors, especially for medical use |
09/26/2012 | CN102695547A Methods and compositions for treating leukemia |
09/26/2012 | CN102695546A Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
09/26/2012 | CN102695545A Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof |
09/26/2012 | CN102695520A Modulating interstitial pressure and oncolytic viral delivery and distribution |
09/26/2012 | CN102695515A Agent for preventing or treating Crohn's disease, comprising organic acid polymer |
09/26/2012 | CN102695514A S-adenosylmethionine formulations with enhanced bioavailability |
09/26/2012 | CN102695513A Nucleoside phosphoramidates |
09/26/2012 | CN102695512A Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
09/26/2012 | CN102695511A Use of transforming growth factor-Beta receptor inhibitors to suppress ocular scarring |
09/26/2012 | CN102695510A Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor |
09/26/2012 | CN102695509A Novel photosensitizer formulations for oral administration |
09/26/2012 | CN102695508A Use of opioid receptor antagonist for gastrointestinal tract disorders |
09/26/2012 | CN102695507A Combination therapy for treating cancer and diagnostic assays for use therein |
09/26/2012 | CN102695506A N-piperidinyl acetamide derivatives as calcium channel blockers |
09/26/2012 | CN102695505A Isothiozoles for treating conditions of the eye |
09/26/2012 | CN102695504A Combination cancer therapy with HSP90 inhibitory compounds |
09/26/2012 | CN102695503A Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms |
09/26/2012 | CN102695502A Compositions for treating drug addiction and improving addiction-related behavior |
09/26/2012 | CN102695498A Compositions & methods for lowering intraocular pressure |
09/26/2012 | CN102695496A Aerosol formulation for COPD |
09/26/2012 | CN102695495A Coloring composition containing an aromatic compound and tyrosinase |
09/26/2012 | CN102695418A Therapeutic vitamin D sun-protecting formulations and methods for their use |
09/26/2012 | CN102695417A Compounds and methods for kinase modulation, and indications therefor |
09/26/2012 | CN102695416A Kinase inhibitors |
09/26/2012 | CN102690857A Method for preparing medium-low molecular weight dextran by using biological method |
09/26/2012 | CN102690445A Mycobacterium polysaccharide, its preparation method and application |
09/26/2012 | CN102690394A Amino-containing cellulose grafted copolymer capable of regulating gastrointestinal smooth muscle |
09/26/2012 | CN102690388A Soluble and blending blood friendly zwitter-ion copolymer, preparation method and application thereof |
09/26/2012 | CN102690326A Novel gossypol derivate with anti-HIV activity and preparation method thereof |
09/26/2012 | CN102690318A Tanshinone II A sodium sulfonate crystal compound, preparation method thereof and medicine composition containing tanshinone II A sodium sulfonate crystal compound |
09/26/2012 | CN102690317A Derivant of 30-halogenated betulinic acid and preparation method and application thereof |
09/26/2012 | CN102690316A Preparation method of glycyrrhetinic acid derivative and medical application thereof in serving as liver-protective medicament |
09/26/2012 | CN102690309A Floxuridine compound and preparation method and application thereof |
09/26/2012 | CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors |
09/26/2012 | CN102690275A Tetrahydrofuro-[3,4-c]pyranyl-4-ketone compound and its preparation method and use |
09/26/2012 | CN102690270A Pyrimidine compound and purpose thereof |
09/26/2012 | CN102690269A Trifluoro methyl substituted quinoline or quinoxaline compound and preparation method thereof, and pharmaceutical composition containing the compound and purpose thereof |
09/26/2012 | CN102690265A 4-substituted azaadamantane derivatives and methods of use thereof |
09/26/2012 | CN102690264A 2-phenyl-3-substituted-imidazo[1,2-a]pyridine derivatives and preparation method thereof |
09/26/2012 | CN102690262A Lead compound of targeting human La protein and purpose thereof in preparation of medicament for resisting hepatitis B virus |
09/26/2012 | CN102690261A Preparation method of 1,4-benzodioxan-containing 1,3,4-oxadiazole derivatives and use of the 1,4-benzdioxan-containing 1,3,4-oxadiazole derivatives in anti-cancer drugs |
09/26/2012 | CN102690259A Compound with function of diuresis, preparation method and functions thereof |
09/26/2012 | CN102690247A Furan compound, preparation method and application of same |
09/26/2012 | CN102690244A Substances regulating alpha-synuclein accumulation and its pharmaceutical application |
09/26/2012 | CN102690240A Tolyltriazole alkene ether compounds and oxime ether compounds and preparation method and application thereof |
09/26/2012 | CN102690238A Synthesis of barbituric acid derivative as RSK2 inhibitor and application thereof |
09/26/2012 | CN102690234A Novel crystal forms of substituted phenylalkanoic acids and process for producing the same |
09/26/2012 | CN102690221A 改性的拟赖氨酸化合物 Proposed modification of lysine compound |
09/26/2012 | CN102690210A Novel crystal form VII of agomelatine, preparation method and application thereof and pharmaceutical composition containing the same |
09/26/2012 | CN102690209A Mixed crystal of agomelatine (form-VIII), preparation method and application thereof and pharmaceutical composition containing the same |
09/26/2012 | CN102688501A Proanthocyanidin B2 phospholipid compound, and preparation method and application thereof |
09/26/2012 | CN102688500A Beta-cyclodextrin clathrating technique for borneol in Saimeian emulsifiable paste |
09/26/2012 | CN102688498A Taxanes-carboxymethyl chitosan amphiphilic macromolecule prodrug, micelle agent and freeze-dried micelle agent, as well as preparation methods thereof |
09/26/2012 | CN102688493A Pharmaceutical composition containing resveratrol, resveratrol derivative and Bc1-2 inhibitor, and application thereof |
09/26/2012 | CN102688492A Compositions and methods for anti-inflammatory treatments |
09/26/2012 | CN102688490A Pharmaceutical composition containing evodiamine, evodiamine derivative and Bc1-2 inhibitor, and the application |
09/26/2012 | CN102688489A Pharmaceutical composition containing triptolide, triptolide derivative and Bc1-2 inhibitor and application thereof |
09/26/2012 | CN102688481A Injection for nourishing myocardium |
09/26/2012 | CN102688479A Composition for preventing xerophthalmia, eye mask with composition and preparation method of eye mask |
09/26/2012 | CN102688478A Injection for treating premature ovarian failure |
09/26/2012 | CN102688477A Medicinal composition for treating respiratory diseases of livestock |
09/26/2012 | CN102688473A Externally applied medicine for treating bone fracture and preparation method thereof |
09/26/2012 | CN102688471A Compound preparation for preventing fatigue |
09/26/2012 | CN102688450A Local use antalgic traditional Chinese medicine composition as well as preparation method and application thereof |
09/26/2012 | CN102688448A Chinese medicinal composition for treating cervical ectopic columnar epithelium |
09/26/2012 | CN102688430A Traditional Chinese medicine composition for treating pig eczema, feed, as well as preparation method and application of traditional Chinese composition |
09/26/2012 | CN102688416A Nutritional health-care product for improving agrypnia |
09/26/2012 | CN102688370A Oral liquid preparation replacing antibiotic and treating yellow scour of newborn piglets, preparation method thereof and usage |
09/26/2012 | CN102688362A Medicine composition for treating epilepsy by combined treatment of traditional Chinese medicine and western medicine |
09/26/2012 | CN102688361A Traditional Chinese medicinal composition for treating dysmenorrhoea and preparation thereof |
09/26/2012 | CN102688358A Suppository for treating prostatitis and preparation method thereof |
09/26/2012 | CN102688334A Chinese and western medicine mixture for improving immunologic function of livestock and preparation method thereof |